vs

Side-by-side financial comparison of VerifyMe, Inc. (VRME) and Wave Life Sciences Ltd. (WVE). Click either name above to swap in a different company.

Wave Life Sciences Ltd. is the larger business by last-quarter revenue ($8.7M vs $5.0M, roughly 1.7× VerifyMe, Inc.). VerifyMe, Inc. runs the higher net margin — -66.7% vs -580.2%, a 513.5% gap on every dollar of revenue. On growth, VerifyMe, Inc. posted the faster year-over-year revenue change (-7.4% vs -55.8%). Over the past eight quarters, VerifyMe, Inc.'s revenue compounded faster (-5.2% CAGR vs -18.0%).

VerifyMe, Inc. is a technology provider specializing in identity verification, anti-counterfeiting, and brand protection solutions. Its offerings include secure authentication tools, supply chain traceability systems, and customer engagement platforms, serving consumer goods, pharmaceutical, and retail sectors across North America and select global markets.

BIT Life Sciences is a for profit meetings, incentives, conferencing, exhibitions (MICE) company based in Dalian, China, that specializes in arranging multiple scientific congresses that have been described as "predatory". The company is part of a wave of organizations that have appeared in China in the past several years noted for arranging congresses with little academic merit and with the primary aim of generating revenue rather than scientific knowledge sharing. Papers submitted are usual...

VRME vs WVE — Head-to-Head

Bigger by revenue
WVE
WVE
1.7× larger
WVE
$8.7M
$5.0M
VRME
Growing faster (revenue YoY)
VRME
VRME
+48.4% gap
VRME
-7.4%
-55.8%
WVE
Higher net margin
VRME
VRME
513.5% more per $
VRME
-66.7%
-580.2%
WVE
Faster 2-yr revenue CAGR
VRME
VRME
Annualised
VRME
-5.2%
-18.0%
WVE

Income Statement — Q3 FY2025 vs Q2 FY2025

Metric
VRME
VRME
WVE
WVE
Revenue
$5.0M
$8.7M
Net Profit
$-3.4M
$-50.5M
Gross Margin
41.2%
Operating Margin
-68.2%
-606.5%
Net Margin
-66.7%
-580.2%
Revenue YoY
-7.4%
-55.8%
Net Profit YoY
-38.4%
-53.3%
EPS (diluted)
$-0.26
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
VRME
VRME
WVE
WVE
Q3 25
$5.0M
Q2 25
$4.5M
$8.7M
Q1 25
$4.5M
$9.2M
Q3 24
$5.4M
Q2 24
$5.4M
$19.7M
Q1 24
$5.8M
$12.5M
Q4 23
$8.7M
$29.1M
Q3 23
$5.6M
$49.2M
Net Profit
VRME
VRME
WVE
WVE
Q3 25
$-3.4M
Q2 25
$-291.0K
$-50.5M
Q1 25
$-571.0K
$-46.9M
Q3 24
$-2.4M
Q2 24
$-346.0K
$-32.9M
Q1 24
$-553.0K
$-31.6M
Q4 23
$2.0K
$-16.3M
Q3 23
$-930.0K
$7.3M
Gross Margin
VRME
VRME
WVE
WVE
Q3 25
41.2%
Q2 25
35.2%
Q1 25
33.4%
Q3 24
34.9%
Q2 24
39.1%
Q1 24
39.2%
Q4 23
33.0%
Q3 23
36.5%
Operating Margin
VRME
VRME
WVE
WVE
Q3 25
-68.2%
Q2 25
-7.1%
-606.5%
Q1 25
-13.3%
-542.8%
Q3 24
-52.8%
Q2 24
-10.0%
-177.7%
Q1 24
-11.2%
-274.8%
Q4 23
0.8%
-64.3%
Q3 23
-15.3%
9.0%
Net Margin
VRME
VRME
WVE
WVE
Q3 25
-66.7%
Q2 25
-6.4%
-580.2%
Q1 25
-12.8%
-510.9%
Q3 24
-44.6%
Q2 24
-6.5%
-167.2%
Q1 24
-9.6%
-251.7%
Q4 23
0.0%
-55.9%
Q3 23
-16.6%
14.7%
EPS (diluted)
VRME
VRME
WVE
WVE
Q3 25
$-0.26
Q2 25
$-0.02
$-0.31
Q1 25
$-0.05
$-0.29
Q3 24
$-0.23
Q2 24
$-0.03
$-0.25
Q1 24
$-0.05
$-0.24
Q4 23
$0.00
$-0.14
Q3 23
$-0.09
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
VRME
VRME
WVE
WVE
Cash + ST InvestmentsLiquidity on hand
$208.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$11.1M
$139.3M
Total Assets
$13.3M
$252.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
VRME
VRME
WVE
WVE
Q3 25
Q2 25
$208.5M
Q1 25
$243.1M
Q3 24
$2.6M
Q2 24
$2.9M
$154.0M
Q1 24
$2.8M
$180.9M
Q4 23
$3.0M
$200.4M
Q3 23
$2.9M
$139.9M
Total Debt
VRME
VRME
WVE
WVE
Q3 25
Q2 25
Q1 25
Q3 24
$500.0K
Q2 24
$600.0K
Q1 24
$800.0K
Q4 23
$875.0K
Q3 23
$1.0M
Stockholders' Equity
VRME
VRME
WVE
WVE
Q3 25
$11.1M
Q2 25
$14.4M
$139.3M
Q1 25
$14.6M
$171.8M
Q3 24
$10.3M
Q2 24
$12.3M
$-3.5M
Q1 24
$12.4M
$25.4M
Q4 23
$39.6M
Q3 23
$11.9M
$-40.5M
Total Assets
VRME
VRME
WVE
WVE
Q3 25
$13.3M
Q2 25
$17.2M
$252.4M
Q1 25
$17.1M
$288.3M
Q3 24
$14.8M
Q2 24
$17.5M
$208.8M
Q1 24
$17.9M
$235.3M
Q4 23
$20.7M
$274.9M
Q3 23
$18.8M
$199.9M
Debt / Equity
VRME
VRME
WVE
WVE
Q3 25
Q2 25
Q1 25
Q3 24
0.05×
Q2 24
0.05×
Q1 24
0.06×
Q4 23
Q3 23
0.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
VRME
VRME
WVE
WVE
Operating Cash FlowLast quarter
$243.0K
$-46.0M
Free Cash FlowOCF − Capex
$-46.3M
FCF MarginFCF / Revenue
-532.5%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-170.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
VRME
VRME
WVE
WVE
Q3 25
$243.0K
Q2 25
$710.0K
$-46.0M
Q1 25
$-404.0K
$-63.0M
Q3 24
$-10.0K
Q2 24
$372.0K
$-27.5M
Q1 24
$-60.0K
$-33.4M
Q4 23
$843.0K
$-33.2M
Q3 23
$-136.0K
$-34.5M
Free Cash Flow
VRME
VRME
WVE
WVE
Q3 25
Q2 25
$-46.3M
Q1 25
$-63.2M
Q3 24
$-12.0K
Q2 24
$369.0K
$-27.5M
Q1 24
$-62.0K
$-33.8M
Q4 23
$840.0K
$-33.6M
Q3 23
$-34.7M
FCF Margin
VRME
VRME
WVE
WVE
Q3 25
Q2 25
-532.5%
Q1 25
-688.9%
Q3 24
-0.2%
Q2 24
6.9%
-139.8%
Q1 24
-1.1%
-270.0%
Q4 23
9.6%
-115.6%
Q3 23
-70.4%
Capex Intensity
VRME
VRME
WVE
WVE
Q3 25
Q2 25
3.5%
Q1 25
1.8%
Q3 24
0.0%
Q2 24
0.1%
0.3%
Q1 24
0.0%
3.3%
Q4 23
0.0%
1.2%
Q3 23
0.0%
0.4%
Cash Conversion
VRME
VRME
WVE
WVE
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
Q1 24
Q4 23
421.50×
Q3 23
-4.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

VRME
VRME

Proactive Services$4.2M83%
Other$869.0K17%

WVE
WVE

Segment breakdown not available.

Related Comparisons